20 March 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

20 March 2017 | n=41

  1. Mcallister J, Towns JM, Mcnulty A, Pierce AB, et al.
    Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
    AIDS 2017.

  2. Mangal TD.
    Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
    AIDS 2017.

  3. Mota TM, Rasmussen TA, Rhodes A, Tennakoon S, et al.
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    AIDS 2017.

  4. Yang OO, Cumberland WG, Escobar R, Liao D, et al.
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS 2017.

  5. Kanthula R, Rossouw T, Feucht UD, Van Dyk G, et al.
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS 2017.

  6. Mahy M, Penazzato M, Ciaranello A, Mofenson L, et al.
    Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    AIDS 2017;31 S:S13-S22.

  7. Wilson KC, Mhangara M, Dzangare J, Eaton JW, et al.
    Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
    AIDS 2017;31 S:S95-S102.

  8. Sheng B, Marsh K, Slavkovic AB, Gregson S, et al.
    Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates.
    AIDS 2017;31 S:S87-S94.

  9. Masquelier B, Eaton JW, Gerland P, Pelletier F, et al.
    Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    AIDS 2017;31 S:S77-S85.

  10. Marston M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al.
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability.
    AIDS 2017;31 S:S69-S76.

  11. Eaton JW, Bao L.
    Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.
    AIDS 2017;31 S:S61-S68.

  12. Niu X, Zhang A, Brown T, Puckett R, et al.
    Incorporation of hierarchical structure into estimation and projection package fitting with examples of estimating subnational HIV/AIDS dynamics.
    AIDS 2017;31 S:S51-S59.

  13. Silhol R, Gregson S, Nyamukapa C, Mhangara M, et al.
    Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    AIDS 2017;31 S:S41-S50.

  14. Anderegg N, Johnson LF, Zaniewski E, Althoff KN, et al.
    All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    AIDS 2017;31 S:S31-S40.

  15. Mahiane SG, Marsh K, Grantham K, Crichlow S, et al.
    Improvements in Spectrum's fit to program data tool.
    AIDS 2017;31 S:S23-S30.

  16. Stover J, Brown T, Puckett R, Peerapatanapokin W, et al.
    Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    AIDS 2017;31 S:S5-S11.

  17. Case KK, Gregson S, Mahy M, Ghys PD, et al.
    Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates.
    AIDS 2017;31 S:S1-S4.

  18. Negi BS, Kotaki T, Joshi SK, Bastola A, et al.
    Genotypic characterization of human immunodeficiency virus type 1 derived from antiretroviral drug-treated individuals residing in earthquake-affected areas in Nepal.
    AIDS Res Hum Retroviruses 2017.

  19. Li F, Li Y, Feng Y, Hu J, et al.
    Four close related HIV-1 CRF01_AE/CRF07_BC Recombinant Forms identified in east China.
    AIDS Res Hum Retroviruses 2017.

  20. Christensen B, Qin Z, Byrd DA, Yu F, et al.
    Measures of Physical and Mental Independence among HIV-positive Individuals: Impact of Substance Use Disorder.
    AIDS Res Hum Retroviruses 2017.

  21. Wang Y, Kong D, Xu W, Li F, et al.
    Identification of a Novel HIV Type 1 CRF01_AE/B'/C Recombinant Isolate in Sichuan, China.
    AIDS Res Hum Retroviruses 2017.

  22. Hey-Nguyen WJ, Xu Y, Pearson CF, Bailey M, et al.
    Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy.
    AIDS Res Hum Retroviruses 2017.

  23. .
    Black Women Make Progress in Reducing HIV Disparity.
    JAMA 2017;317:1010.

  24. .
    Blacks Still Trail in HIV Care.
    JAMA 2017;317:1010.

  25. Carey AL, Khan MU, Engleberg NC.
    A 24-Year-Old Man With a Left Frontal Brain Mass.
    JAMA 2017;317:527-528.

  26. Lui G, Ma RC, Chook P, Wong CK, et al.
    Progression of Atherosclerosis in HIV-infected Individuals - Prospective Data from an Asian Cohort.
    J Acquir Immune Defic Syndr 2017.

  27. Nachega JB, Uthman OA, Mofenson LM, Anderson JR, et al.
    Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr 2017.

  28. Teeraananchai S, Bunupuradah T, Puthanakit T, Kerr SJ, et al.
    First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand.
    J Acquir Immune Defic Syndr 2017.

  29. Coelho LE, Ribeiro SR, Japiassu AM, Moreira RI, et al.
    30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr 2017.

  30. Thomson KA, Haberer JE, Marzinke M, Mujugira A, et al.
    Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
    J Acquir Immune Defic Syndr 2017.

  31. Tomita A, Vandormael AM, Barnighausen T, de Oliveira T, et al.
    Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa.
    J Acquir Immune Defic Syndr 2017.

  32. Kahn J, Xu J, Kapogiannis BG, Sleasman JW, et al.
    Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
    J Acquir Immune Defic Syndr 2017.

  33. Kasaie P, Pennington J, Shah MS, Berry SA, et al.
    The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr 2017.

  34. Arribas JR, Thompson M, Sax PE, Haas B, et al.
    A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.
    J Acquir Immune Defic Syndr 2017.

  35. Baig TT, Feng Y, Chelico L.
    Correction for Baig et al., Determinants of Efficient Degradation of APOBEC3 Restriction Factors by HIV-1 Vif.
    J Virol 2017;91.

  36. Huffman MD, Xavier D, Perel P.
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet 2017;389:1055-1065.

  37. Haynes BF, Burton DR.
    Developing an HIV vaccine.
    Science 2017;355:1129-1130.

  38. Naldini L, Trono D, Verma IM.
    Lentiviral vectors, two decades later.
    Science 2016;353:1101-2.

  39. Crooks ET, Osawa K, Tong T, Grimley SL, et al.
    Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.
    Virology 2017;505:193-209.

  40. Van de Perre P, Kankasa C, Nagot N, Meda N, et al.
    Pre-exposure prophylaxis for infants exposed to HIV through breast feeding.
    BMJ 2017;356:j1053.

  41. Khan M, Rao PK, Rao RC.
    A brushfire in the eye.
    BMJ 2016;353:i3075.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

20 March 2017

13 March 2017

06 March 2017

27 February 2017

20 February 2017

20 March 2017

Multidisciplinary Journal Club

  1. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, et al.
    Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2016;316:2525-2530.

  2. Feltner C, Grodensky C, Ebel C, Middleton JC, et al.
    Serologic Screening for Genital Herpes: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2016;316:2531-2543.

  3. Hochhaus A, Larson RA, Guilhot F, Radich JP, et al.
    Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
    N Engl J Med. 2017;376:917-927.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016